1. Home
  2. LVS vs RMD Comparison

LVS vs RMD Comparison

Compare LVS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Las Vegas Sands Corp.

LVS

Las Vegas Sands Corp.

N/A

Current Price

$36.62

Market Cap

31.2B

ML Signal

N/A

Logo ResMed Inc.

RMD

ResMed Inc.

N/A

Current Price

$221.53

Market Cap

34.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LVS
RMD
Founded
1988
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
34.0B
IPO Year
2004
1996

Fundamental Metrics

Financial Performance
Metric
LVS
RMD
Price
$36.62
$221.53
Analyst Decision
Buy
Buy
Analyst Count
21
20
Target Price
$59.07
★ $250.22
AVG Volume (30 Days)
★ 4.4M
865.9K
Earning Date
10-21-2026
10-29-2026
Dividend Yield
★ 3.17%
1.19%
EPS Growth
★ 19.90
9.67
EPS
1.38
★ 10.43
Revenue
★ $13,017,000,000.00
$2,957,013,000.00
Revenue This Year
$6.01
$2.70
Revenue Next Year
$5.48
$6.30
P/E Ratio
$27.81
★ $21.09
Revenue Growth
★ 15.22
13.44
52 Week Low
$38.06
$180.27
52 Week High
$70.45
$284.87

Technical Indicators

Market Signals
Indicator
LVS
RMD
Relative Strength Index (RSI) 20.49 45.70
Support Level N/A $217.10
Resistance Level $55.13 $222.43
Average True Range (ATR) 0.89 4.55
MACD -0.19 -0.70
Stochastic Oscillator 1.78 17.89

Price Performance

Historical Comparison
LVS
RMD

About LVS Las Vegas Sands Corp.

Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner Macao, Four Seasons Hotel Macao, and Parisian Macao, as well as the Marina Bay Sands resort in Singapore. We expect Sands to open a fourth tower in Singapore in 2031. Its Venetian and Palazzo Las Vegas assets in the US were sold to Apollo and Vici in 2022. After the sale of its Vegas assets, Sands generates all its EBITDA from Asia, with its casino operations generating the majority of sales.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: